Nickel-induced 1,4-α-glucan branching enzyme 1 up-regulation via the hypoxic signaling pathway

Toxicology and Applied Pharmacology

Volumn 196, Issue 3, 2004, Pages 404-409

  Zhao, Jianhua ^a   Chen, Haobin ^a   Davidson, Todd ^a   Kluz, Thomas ^a   Zhang, Qunwei ^a   Costa, Max ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GBE1; HIF 1 ; Nickel

Indexed keywords

1,4 ALPHA GLUCAN BRANCHING ENZYME; COBALT; DEFEROXAMINE; DIMETHYLOXALYLGLYCINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICKEL; OXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; EMBRYO; GENE CONTROL; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; NORTHERN BLOTTING; SIGNAL TRANSDUCTION; UPREGULATION;

1,4-ALPHA-GLUCAN BRANCHING ENZYME; ANIMALS; ANOXIA; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; NICKEL; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 1942535773     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.01.012     Document Type: Article

References (16)

1. Bao Y., Kishnani P., Wu J.Y., Chen Y.T. 1Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J. Clin. Invest. 97(4):1996;941-948.
2. Costa M. Mechanism of nickel genotoxicity and carcinogenicity. Chang L.W., Magos L., Suzuki T. Toxicology of Metals. 1996;245-251 Lewis, New York.
3. Costa M., Yan Y., Zhao D., Salnikow K. Molecular mechanisms of nickel carcinogenesis: gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling. J. Environ. Monit. 5(2):2003;22-23.
4. Dunnick J.K., Elwell M.R., Radovsky A.E., Benson J.M., Hahn F.F., Nikula K.J., Barr E.B., Hobbs C.H. Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res. 55(22):1995;5251-5256.
5. IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Chromium, Nickel and Welding. vol. 49:1990;IARC, Lyon, France.
6. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274(10):1999;6519-6525.
7. Klein C.B., Conway K., Wang X.W., Bhamra R.K., Lin X.H., Cohen M.D., Annab L., Barrett J.C., Costa M. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science. 251(4995):1991;796-799.
8. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 295(1):2002;858-861.
9. Lee Y.W., Klein C.B., Kargacin B., Salnikow K., Kitahara J., Dowjat K., Zhitkovich A., Christie N.T., Costa M. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol. Cell. Biol. 15(5):1995;2547-2557.
10. Salnikow K., Blagosklonny M.V., Ryan H., Johnson R., Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60(1):2000;38-41.
11. Salnikow K., Davidson T., Kluz T., Chen H., Zhou D., Costa M. GeneChip analysis of signaling pathways effected by nickel. J. Environ. Monit. 5(2):2003;206-209.
12. Salnikow K., Davidson T., Zhang Q., Chen L.C., Su W., Costa M. The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res. 63(13):2003;3524-3530.
13. Semenza G.L. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59(1):2000;47-53.
14. Shi N., Boado R.J., Pardridge W.M. Antisense imaging of gene expression in the brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 97(26):2000;14709-14714.
15. Yan Y., Kluz T., Zhang P., Chen H., Costa M. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol. Appl. Pharmacol. 190(3):2003;272-277.
16. Zhao J., Yan Y., Salnikow K., Kluz T., Costa M. Nickel-induced serpin down-regulation by hypoxic signaling. Toxicol. Appl. Pharmacol. 2003;. (in press).